2.4% placebo) 86.4% of participants lost at least 5% of body weight 69.1% lost at least 10% 50.5% lost at least 15% STEP 3 (Wadden et al., 2021, JAMA ): Combined with intensive behavioral therapy Average weight loss: 16.0% over 68 weeks Demonstrated that lifestyle support amplifies medication effects STEP 5 (Garvey et al., 2022, Nature Medicine ): Two-year duration study Average weight loss: 15.2% maintained over 104 weeks Demonstrated sustained effectiveness with continued use Retatrutide Clinical Trial Results Phase 2 Trial (Jastreboff et al., 2023, NEJM ): 338 adults with obesity (BMI 30+) or overweight (BMI 27+) with comorbidities Multiple dose groups (1 mg, 4 mg, 8 mg, 12 mg weekly) Results at the 12 mg dose: Average weight loss: 24.2% in 48 weeks 100% of participants lost at least 5% of body weight 93% lost at least 10% 83% lost at least 15% 63% lost at least 20% Weight loss trajectory had not plateaued at study end Comprehensive Comparison Table Side Effects Comparison Both medications share similar gastrointestinal side effect profiles because they both activate GLP-1 receptors

The checkouts Select Your Treatment Plan panel opens with 6-Month Supply $990 pre-selected and a Get 2 Months Free badge attached
In the landmark SURMOUNT-1 study, which evaluated adults with obesity or overweight without type 2 diabetes over a 72-week treatment duration, the results were highly significant: Participants taking the maximum 15 mg dose achieved an average weight loss of 22.5% of their baseline body weight
Li ch v nguy c khi s dng cc loi thuc ny gim cn ca nhng ngi khng b bo ph hoc khng tha cn c bnh i km lin quan n cn nng vn cha c nghin cu
Alcohol use should also be limited while taking Contrave
Sesame Care is a legitimate provider of psychiatry and therapy services, as well as other telemedicine offerings